Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial
Fizazi, Karim, Prof, Pagliaro, Lance, Prof, Laplanche, Agnes, MD, Fléchon, Aude, MD, Mardiak, Josef, Prof, Geoffrois, Lionnel, MD, Kerbrat, Pierre, Prof, Chevreau, Christine, MD, Delva, Remy, MD, Rolland, Frederic, MD, Theodore, Christine, MD, Roubaud, Guilhem, MD, Gravis, Gwenaëlle, MD, Eymard, Jean-Christophe, MD, Malhaire, Jean-Pierre, MD, Linassier, Claude, Prof, Habibian, Muriel, Martin, Anne-Laure, Journeau, Florence, Reckova, Maria, MD, Logothetis, Christopher, Prof, Culine, Stephane, Prof
Published in The lancet oncology (01.12.2014)
Published in The lancet oncology (01.12.2014)
Get full text
Journal Article